Target intelligence / Profile preview

Pre-mRNA processing factor 8 (PRPF8)

Target
PRPF8
Molecular classification
Other (Spliceosome core component), Splicing factor, RNA-binding protein
01

Overview

Pre-mRNA processing factor 8 (PRPF8) is a **central and evolutionarily conserved core component of the spliceosome**, essential for the catalysis of pre-mRNA splicing in eukaryotes[1][2][3]. PRPF8 orchestrates the assembly, structural arrangement, and proper function of U2- and U12-dependent spliceosomes by serving as a molecular scaffold that mediates protein-protein and protein-RNA interactions[2][3]. Structurally, it contains WD repeat motifs involved in interactions and domains (e.g., Jab1/MPN and RNase H–like) that regulate catalytic activation and splice site selection, especially through interaction with the DEAD-box helicase Brr2[1][4]. PRPF8 is required for the quality control of U5 snRNP assembly, alternative splicing regulation, and the fidelity of intron removal—a critical determinant of tissue-specific gene expression[1][4]. Mutations in PRPF8, particularly in its C-terminal domain, are a leading cause of autosomal dominant **retinitis pigmentosa** and other retinal/ciliary disorders, with tissue vulnerability linked to high splicing demand in retinal cells[1][2][4]. There are currently no known direct drugs targeting PRPF8, as it is an essential and ubiquitously required component, and therapeutic targeting presents challenges due to risk of systemic transcriptome disruption[1][4].

Other names
HPRP8PRPC8SNRNP220RP13PRP8Pre-mRNA-processing-splicing factor 8220 kDa U5 snRNP-specific proteinPRP8 homologp220
02

Biological functions

Pre-mRNA splicingAlternative splicing regulationSpliceosome assembly and catalytic activationProtein-protein interaction scaffoldingControl of gene expression fidelity
03

Disease associations

Retinitis pigmentosa (type 13 and others)Neurodevelopmental disordersOcular diseases (primary open angle glaucoma)Other diseases linked to splicing dysfunction
04

Safety considerations

Mutations can cause widespread splicing defects most pronounced in retinal cellsAny targeting of spliceosome function carries possible risk of widespread transcriptomic disruption
05

Biomarkers

Mutations in PRPF8 (notably C-terminal region) are biomarkers for autosomal dominant retinitis pigmentosa

Beyond the preview

Go deeper on Pre-mRNA processing factor 8 (PRPF8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pre-mRNA processing factor 8 (PRPF8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call